Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.5 USD | -0.18% |
|
+1.28% | -0.37% |
Jul. 01 | Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from Russell 2000 Defensive Index | CI |
Jul. 01 | Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from Russell 2000 Value-Defensive Index | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.37% | 507M | C+ | ||
-5.97% | 178B | C+ | ||
-5.71% | 98.95B | C | ||
-6.58% | 66.14B | A | ||
-8.53% | 44.11B | B- | ||
+8.01% | 43.82B | B- | ||
+10.10% | 42.74B | B+ | ||
+11.12% | 28.92B | B | ||
+18.89% | 25.06B | A- | ||
-8.71% | 23.38B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- OFIX Stock
- Ratings Orthofix Medical Inc.